Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

Short-lived IFN-γ effector responses, but long-lived IL-10 memory responses, to malaria in an area of low malaria endemicity.
Wipasa, J; Okell, L; Sakkhachornphop, S; Suphavilai, C; Chawansuntati, K; Liewsaree, W; HAFALLA, JC R; RILEY, EM;
2011
PLoS pathogens, (2011).7 2 10.1371/journal.ppat.1001281.
The role of antimalarial treatment in the elimination of malaria.
GOSLING, RD; Okell, L; Mosha, J; CHANDRAMOHAN, D;
2011
Clinical microbiology and infection, (2011).17 11 10.1111/j.1469-0691.2011.03660.x.
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.
Mombo-Ngoma, G; Oyakhirome, S; Ord, R; Gabor, JJ; Greutélaers, KC; Profanter, K; Greutélaers, B; Kurth, F; Lell, B; Kun, JF J; Issifou, S; ROPER, C; Kremsner, PG; Grobusch, MP;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-123.
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient care.
Vekemans, J; Marsh, K; GREENWOOD, B; Leach, A; Kabore, W; Soulanoudjingar, S; ASANTE, KP; Ansong, D; Evans, J; Sacarlal, J; Bejon, P; Kamthunzi, P; Salim, N; Njuguna, P; Hamel, MJ; Otieno, W; Gesase, S; SCHELLENBERG, D; Clinical Trials Partnership Committee,;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-221.
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Mali: a randomised, double-blind, placebo-controlled trial.
Dicko, A; Diallo, AI; Tembine, I; Dicko, Y; Dara, N; Sidibe, Y; Santara, G; Diawara, H; Conaré, T; Djimde, A; CHANDRAMOHAN, D; COUSENS, S; MILLIGAN, PJ; Diallo, DA; Doumbo, OK; GREENWOOD, B;
2011
PLoS medicine, (2011).8 2 10.1371/journal.pmed.1000407.
Travel clinic communication and non-adherence to malaria chemoprophylaxis.
Farquharson, L; Noble, LM; BEHRENS, RH;
2011
Travel medicine and infectious disease, (2011).9 6 10.1016/j.tmaid.2011.09.004.
Establishing the extent of malaria transmission and challenges facing pre-elimination in the Republic of Djibouti.
Noor, AM; Mohamed, MB; Mugyenyi, CK; Osman, MA; Guessod, HH; Kabaria, CW; Ahmed, IA; Nyonda, M; COOK, J; DRAKELEY, CJ; Mackinnon, MJ; Snow, RW;
2011
BMC infectious diseases, (2011).11 1 10.1186/1471-2334-11-121.
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine.
Swysen, C; Vekemans, J; Bruls, M; Oyakhirome, S; DRAKELEY, C; Kremsner, P; GREENWOOD, B; Ofori-Anyinam, O; Okech, B; Villafana, T; Carter, T; Savarese, B; Duse, A; Reijman, A; Ingram, C; Frean, J; Ogutu, B; Clinical Trials Partnership Committee,;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-223.
Intermittent preventive treatment of malaria provides substantial protection against malaria in children already protected by an insecticide-treated bednet in Burkina Faso: a randomised, double-blind, placebo-controlled trial.
Konaté, AT; Yaro, JB; Ouédraogo, AZ; Diarra, A; Gansané, A; Soulama, I; Kangoyé, DT; Kaboré, Y; Ouédraogo, E; Ouédraogo, A; Tiono, AB; Ouédraogo, IN; CHANDRAMOHAN, D; COUSENS, S; MILLIGAN, PJ; Sirima, SB; GREENWOOD, B; Diallo, DA;
2011
PLoS medicine, (2011).8 2 10.1371/journal.pmed.1000408.
The ACTwatch project: methods to describe anti-malarial markets in seven countries.
Shewchuk, T; O'Connell, KA; GOODMAN, C; HANSON, K; Chapman, S; Chavasse, D;
2011
Malaria journal, (2011).10 1 10.1186/1475-2875-10-325.